Evidence map›Paper›PMID 38174571›Full record

ArticleStroke2024

Intravenous Thrombolysis Before Endovascular Treatment in Posterior Circulation Occlusions: A MR CLEAN Registry Study.

Robrecht R M M Knapen, F Anne V Pirson, Lucianne C M Langezaal, Josje Brouwer, Charles B L M Majoie, Bart J Emmer, Jan-Albert Vos, Pieter-Jan van Doormaal, Albert J Yoo, Agnetha A E Bruggeman and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Stroke, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

Robrecht R M M KnapenDepartment of Radiology and Nuclear Medicine (R.R.M.M.K., C.v.d.L., W.H.v.Z.), Maastricht University Medical Center, the Netherlands.ORCID 0000-0003-4677-3685
F Anne V PirsonDepartment of Neurology (F.A.V.P.), Haaglanden MC, Hague, the Netherlands.
Lucianne C M LangezaalDepartment of Radiology (L.C.M.L., J.-A.V.), St. Antonius Hospital, Nieuwegein, the Netherlands.ORCID 0000-0001-9725-8777
Josje BrouwerDepartment of Neurology (J.B.), Amsterdam University Medical Center, University of Amsterdam, the Netherlands.ORCID 0000-0003-0301-2616
Charles B L M MajoieDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, University of Amsterdam, the Netherlands (C.B.L.M.M., A.A.E.B.).ORCID 0000-0002-7600-9568
Bart J EmmerDepartment of Radiology and Nuclear Medicine (B.J.E.), Amsterdam University Medical Center, University of Amsterdam, the Netherlands.ORCID 0000-0003-1222-0652
Jan-Albert VosDepartment of Radiology (L.C.M.L., J.-A.V.), St. Antonius Hospital, Nieuwegein, the Netherlands.ORCID 0000-0003-3614-9168
Pieter-Jan van DoormaalDepartment of Radiology, Erasmus Medical Center, University Medical Center, Rotterdam, the Netherlands (P.-J.v.D.).ORCID 0000-0002-7398-2864
Albert J YooDepartment of Radiology/Neurointervention, Texas Stroke Institute, Dallas-Fort Worth (A.J.Y).ORCID 0000-0002-7657-142X
Agnetha A E BruggemanDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, University of Amsterdam, the Netherlands (C.B.L.M.M., A.A.E.B.).ORCID 0000-0002-6873-2545
Geert J Lycklama À NijeholtDepartment of Radiology (G.J.L.à.N.), Haaglanden MC, Hague, the Netherlands.
Chirstiaan van der LeijDepartment of Radiology and Nuclear Medicine (R.R.M.M.K., C.v.d.L., W.H.v.Z.), Maastricht University Medical Center, the Netherlands.ORCID 0000-0003-0170-1012
Robert J van OostenbruggeDepartment of Neurology (R.J.v.O.), Maastricht University Medical Center, the Netherlands.ORCID 0000-0003-1032-9099
Wim H van ZwamDepartment of Radiology and Nuclear Medicine (R.R.M.M.K., C.v.d.L., W.H.v.Z.), Maastricht University Medical Center, the Netherlands.ORCID 0000-0003-1631-7056
Wouter J SchonewilleDepartment of Neurology (W.J.S.), St. Antonius Hospital, Nieuwegein, the Netherlands.
MR CLEAN Registry Investigators
St. Antonius Ziekenhuis · NLMaastricht University · NLAmsterdam University Medical Centers · NLGGD Haaglanden · NLJPS Health Network · USErasmus MC · NLMaastricht University Medical Centre · NLUnited States Army Reserve · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe effectiveness of intravenous thrombolysis (IVT) before endovascular treatment (EVT) has been investigated in randomized trials and meta-analyses. These studies mainly concerned anterior circulation occlusions. We aimed to investigate clinical, technical, and safety outcomes of IVT before EVT in posterior circulation occlusions in a nationwide registry.

methodsPatients were included from the MR CLEAN Registry (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands), a nationwide, prospective, multicenter registry of patients with acute ischemic stroke due to a large intracranial vessel occlusion receiving EVT between 2014 and 2019. All patients with a posterior circulation occlusion were included. Primary outcome was a shift toward better functional outcome on the modified Rankin Scale at 90 days. Secondary outcomes were favorable functional outcome (modified Rankin Scale scores, 0-3), occurrence of symptomatic intracranial hemorrhages, successful reperfusion (extended Thrombolysis in Cerebral Ischemia ≥2B), first-attempt successful reperfusion, and mortality at 90 days. Regression analyses with adjustments based on univariable analyses and literature were applied.

resultsA total of 248 patients were included, who received either IVT (n=125) or no IVT (n=123) before EVT. Results show no differences in a shift on the modified Rankin Scale (adjusted common odds ratio, 1.04 [95% CI, 0.61-1.76]). Although symptomatic intracranial hemorrhages occurred more often in the IVT group (4.8% versus 2.4%), regression analysis did not show a significant difference (adjusted odds ratio, 1.65 [95% CI, 0.33-8.35]). Successful reperfusion, favorable functional outcome, first-attempt successful reperfusion, and mortality did not differ between patients treated with and without IVT.

conclusionsWe found no significant differences in clinical, technical, and safety outcomes between patients with a large vessel occlusion in the posterior circulation treated with or without IVT before EVT. Our results are in line with the literature on the anterior circulation.

Indexed as

Endovascular ProceduresIschemic StrokeThrombolytic TherapyHumansIntracranial HemorrhagesMulticenter Studies as TopicProspective StudiesRandomized Controlled Trials as TopicRegistriesTreatment Outcomeposterior circulationstrokethrombectomythrombolytic therapy

Identifiers

PMID38174571
PMCPMC10802980
OpenAlexW4390586759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.